Pharmaceutical Third-Party Logistics Market Size, Share & Trends Report

Pharmaceutical Third-Party Logistics Market (2025 - 2030) Size, Share & Trends Analysis Report By Product (Branded, Generic, Biosimilar), By Temperature (Ambient, Refrigerated), By Therapeutic Area, By Manufacturer Size, By Service, By Region, And Segment Forecasts

Market Segmentation

Pharmaceutical Third-Party Logistics Product Outlook (Revenue, USD Million, 2018 - 2030)
- Branded
- Generic
- Biosimilar
- Vaccine
- Cell Therapy
- Gene Therapy
- Others
Pharmaceutical Third-Party Logistics Temperature Outlook (Revenue, USD Million, 2018 - 2030)
- Oncology
- Cardiovascular Diseases
- Infectious Diseases
- Neurology
- Diabetes
- Nephrology
- Rheumatology
- Allergy/Asthma
- Gastroenterology
- Ophthalmology
- Others
Pharmaceutical Third-Party Logistics Manufacturer Size Outlook (Revenue, USD Million, 2018 - 2030)
- Large
- Medium
- Small
Pharmaceutical Third-Party Logistics Service Outlook (Revenue, USD Million, 2018 - 2030)
- Storage and Shipping
- Order-to-cash
- Title Model
- DSCSA and Serialization Services
- Pharmaceutical Sampling
- Others
Pharmaceutical Third-Party Logistics Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Pharmaceutical Third-party Logistics (3PL) Market, By Product, 2018 - 2030 (USD Million)
    - Branded
    - Generic
    - Biosimilar
    - Vaccine
    - Cell Therapy
    - Gene Therapy
    - Others
  - North America Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
    - Ambient
    - Refrigerated
    - Frozen
    - Ultra-frozen/Deep-Frozen
    - Cryogenic
  - North America Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
    - Oncology
    - Cardiovascular Diseases
    - Infectious Diseases
    - Neurology
    - Diabetes
    - Nephrology
    - Rheumatology
    - Allergy/Asthma
    - Gastroenterology
    - Ophthalmology
    - Others
  - North America Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
    - Large
    - Medium
    - Small
  - North America Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
    - Storage and Shipping
    - Order-to-cash
    - Title Model
    - DSCSA and Serialization Services
    - Pharmaceutical Sampling
    - Others
  - U.S.
    - U.S. Pharmaceutical Third-party Logistics (3PL) Market, By Product, 2018 - 2030 (USD Million)
      - Branded
      - Generic
      - Biosimilar
      - Vaccine
      - Cell Therapy
      - Gene Therapy
      - Others
    - U.S. Pharmaceutical Third-party Logistics (3PL) Market, By Temperature, 2018 - 2030 (USD Million)
      - Ambient
      - Refrigerated
      - Frozen
      - Ultra-frozen/Deep-Frozen
      - Cryogenic
    - U.S. Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
      - Oncology
      - Cardiovascular Diseases
      - Infectious Diseases
      - Neurology
      - Diabetes
      - Nephrology
      - Rheumatology
      - Allergy/Asthma
      - Gastroenterology
      - Ophthalmology
      - Others
    - U.S. Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
      - Large
      - Medium
      - Small
    - U.S. Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
      - Storage and Shipping
      - Order-to-cash
      - Title Model
      - DSCSA and Serialization Services
      - Pharmaceutical Sampling
      - Others
  - Canada
    - Canada Pharmaceutical Third-party Logistics (3PL) Market, By Product, 2018 - 2030 (USD Million)
      - Branded
      - Generic
      - Biosimilar
      - Vaccine
      - Cell Therapy
      - Gene Therapy
      - Others
    - Canada Pharmaceutical Third-party Logistics (3PL) Market, By Temperature, 2018 - 2030 (USD Million)
      - Ambient
      - Refrigerated
      - Frozen
      - Ultra-frozen/Deep-Frozen
      - Cryogenic
    - Canada Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
      - Oncology
      - Cardiovascular Diseases
      - Infectious Diseases
      - Neurology
      - Diabetes
      - Nephrology
      - Rheumatology
      - Allergy/Asthma
      - Gastroenterology
      - Ophthalmology
      - Others
    - Canada Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
      - Large
      - Medium
      - Small
    - Canada Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
      - Storage and Shipping
      - Order-to-cash
      - Title Model
      - DSCSA and Serialization Services
      - Pharmaceutical Sampling
      - Others
  - Mexico
    - Mexico Pharmaceutical Third-party Logistics (3PL) Market, By Product, 2018 - 2030 (USD Million)
      - Branded
      - Generic
      - Biosimilar
      - Vaccine
      - Cell Therapy
      - Gene Therapy
      - Others
    - Mexico Pharmaceutical Third-party Logistics (3PL) Market, By Temperature, 2018 - 2030 (USD Million)
      - Ambient
      - Refrigerated
      - Frozen
      - Ultra-frozen/Deep-Frozen
      - Cryogenic
    - Mexico Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
      - Oncology
      - Cardiovascular Diseases
      - Infectious Diseases
      - Neurology
      - Diabetes
      - Nephrology
      - Rheumatology
      - Allergy/Asthma
      - Gastroenterology
      - Ophthalmology
      - Others
    - Mexico Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
      - Large
      - Medium
      - Small
    - Mexico Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
      - Storage and Shipping
      - Order-to-cash
      - Title Model
      - DSCSA and Serialization Services
      - Pharmaceutical Sampling
      - Others
- Europe
  - Europe Pharmaceutical Third-party Logistics (3PL) Market, By Product, 2018 - 2030 (USD Million)
    - Branded
    - Generic
    - Biosimilar
    - Vaccine
    - Cell Therapy
    - Gene Therapy
    - Others
  - Europe Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
    - Ambient
    - Refrigerated
    - Frozen
    - Ultra-frozen/Deep-Frozen
    - Cryogenic
  - Europe Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
    - Oncology
    - Cardiovascular Diseases
    - Infectious Diseases
    - Neurology
    - Diabetes
    - Nephrology
    - Rheumatology
    - Allergy/Asthma
    - Gastroenterology
    - Ophthalmology
    - Others
  - Europe Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
    - Large
    - Medium
    - Small
  - Europe Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
    - Storage and Shipping
    - Order-to-cash
    - Title Model
    - DSCSA and Serialization Services
    - Pharmaceutical Sampling
    - Others
  - UK
    - UK Pharmaceutical Third-party Logistics (3PL) Market, By Product, 2018 - 2030 (USD Million)
      - Branded
      - Generic
      - Biosimilar
      - Vaccine
      - Cell Therapy
      - Gene Therapy
      - Others
    - UK Pharmaceutical Third-party Logistics (3PL) Market, By Temperature, 2018 - 2030 (USD Million)
      - Ambient
      - Refrigerated
      - Frozen
      - Ultra-frozen/Deep-Frozen
      - Cryogenic
    - UK Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
      - Oncology
      - Cardiovascular Diseases
      - Infectious Diseases
      - Neurology
      - Diabetes
      - Nephrology
      - Rheumatology
      - Allergy/Asthma
      - Gastroenterology
      - Ophthalmology
      - Others
    - UK Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
      - Large
      - Medium
      - Small
    - UK Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
      - Storage and Shipping
      - Order-to-cash
      - Title Model
      - DSCSA and Serialization Services
      - Pharmaceutical Sampling
      - Others
  - Germany
    - Germany Pharmaceutical Third-party Logistics (3PL) Market, By Product, 2018 - 2030 (USD Million)
      - Branded
      - Generic
      - Biosimilar
      - Vaccine
      - Cell Therapy
      - Gene Therapy
      - Others
    - Germany Pharmaceutical Third-party Logistics (3PL) Market, By Temperature, 2018 - 2030 (USD Million)
      - Ambient
      - Refrigerated
      - Frozen
      - Ultra-frozen/Deep-Frozen
      - Cryogenic
    - Germany Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
      - Oncology
      - Cardiovascular Diseases
      - Infectious Diseases
      - Neurology
      - Diabetes
      - Nephrology
      - Rheumatology
      - Allergy/Asthma
      - Gastroenterology
      - Ophthalmology
      - Others
    - Germany Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
      - Large
      - Medium
      - Small
    - Germany Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
      - Storage and Shipping
      - Order-to-cash
      - Title Model
      - DSCSA and Serialization Services
      - Pharmaceutical Sampling
      - Others
  - France
    - France Pharmaceutical Third-party Logistics (3PL) Market, By Product, 2018 - 2030 (USD Million)
      - Branded
      - Generic
      - Biosimilar
      - Vaccine
      - Cell Therapy
      - Gene Therapy
      - Others
    - France Pharmaceutical Third-party Logistics (3PL) Market, By Temperature, 2018 - 2030 (USD Million)
      - Ambient
      - Refrigerated
      - Frozen
      - Ultra-frozen/Deep-Frozen
      - Cryogenic
    - France Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
      - Oncology
      - Cardiovascular Diseases
      - Infectious Diseases
      - Neurology
      - Diabetes
      - Nephrology
      - Rheumatology
      - Allergy/Asthma
      - Gastroenterology
      - Ophthalmology
      - Others
    - France Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
      - Large
      - Medium
      - Small
    - France Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
      - Storage and Shipping
      - Order-to-cash
      - Title Model
      - DSCSA and Serialization Services
      - Pharmaceutical Sampling
      - Others
  - Italy
    - Italy Pharmaceutical Third-party Logistics (3PL) Market, By Product, 2018 - 2030 (USD Million)
      - Branded
      - Generic
      - Biosimilar
      - Vaccine
      - Cell Therapy
      - Gene Therapy
      - Others
    - Italy Pharmaceutical Third-party Logistics (3PL) Market, By Temperature, 2018 - 2030 (USD Million)
      - Ambient
      - Refrigerated
      - Frozen
      - Ultra-frozen/Deep-Frozen
      - Cryogenic
    - Italy Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
      - Oncology
      - Cardiovascular Diseases
      - Infectious Diseases
      - Neurology
      - Diabetes
      - Nephrology
      - Rheumatology
      - Allergy/Asthma
      - Gastroenterology
      - Ophthalmology
      - Others
    - Italy Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
      - Large
      - Medium
      - Small
    - Italy Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
      - Storage and Shipping
      - Order-to-cash
      - Title Model
      - DSCSA and Serialization Services
      - Pharmaceutical Sampling
      - Others
  - Spain
    - Spain Pharmaceutical Third-party Logistics (3PL) Market, By Product, 2018 - 2030 (USD Million)
      - Branded
      - Generic
      - Biosimilar
      - Vaccine
      - Cell Therapy
      - Gene Therapy
      - Others
    - Spain Pharmaceutical Third-party Logistics (3PL) Market, By Temperature, 2018 - 2030 (USD Million)
      - Ambient
      - Refrigerated
      - Frozen
      - Ultra-frozen/Deep-Frozen
      - Cryogenic
    - Spain Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
      - Oncology
      - Cardiovascular Diseases
      - Infectious Diseases
      - Neurology
      - Diabetes
      - Nephrology
      - Rheumatology
      - Allergy/Asthma
      - Gastroenterology
      - Ophthalmology
      - Others
    - Spain Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
      - Large
      - Medium
      - Small
    - Spain Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
      - Storage and Shipping
      - Order-to-cash
      - Title Model
      - DSCSA and Serialization Services
      - Pharmaceutical Sampling
      - Others
  - Denmark
    - Denmark Pharmaceutical Third-party Logistics (3PL) Market, By Product, 2018 - 2030 (USD Million)
      - Branded
      - Generic
      - Biosimilar
      - Vaccine
      - Cell Therapy
      - Gene Therapy
      - Others
    - Denmark Pharmaceutical Third-party Logistics (3PL) Market, By Temperature, 2018 - 2030 (USD Million)
      - Ambient
      - Refrigerated
      - Frozen
      - Ultra-frozen/Deep-Frozen
      - Cryogenic
    - Denmark Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
      - Oncology
      - Cardiovascular Diseases
      - Infectious Diseases
      - Neurology
      - Diabetes
      - Nephrology
      - Rheumatology
      - Allergy/Asthma
      - Gastroenterology
      - Ophthalmology
      - Others
    - Denmark Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
      - Large
      - Medium
      - Small
    - Denmark Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
      - Storage and Shipping
      - Order-to-cash
      - Title Model
      - DSCSA and Serialization Services
      - Pharmaceutical Sampling
      - Others
  - Sweden
    - Sweden Pharmaceutical Third-party Logistics (3PL) Market, By Product, 2018 - 2030 (USD Million)
      - Branded
      - Generic
      - Biosimilar
      - Vaccine
      - Cell Therapy
      - Gene Therapy
      - Others
    - Sweden Pharmaceutical Third-party Logistics (3PL) Market, By Temperature, 2018 - 2030 (USD Million)
      - Ambient
      - Refrigerated
      - Frozen
      - Ultra-frozen/Deep-Frozen
      - Cryogenic
    - Sweden Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
      - Oncology
      - Cardiovascular Diseases
      - Infectious Diseases
      - Neurology
      - Diabetes
      - Nephrology
      - Rheumatology
      - Allergy/Asthma
      - Gastroenterology
      - Ophthalmology
      - Others
    - Sweden Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
      - Large
      - Medium
      - Small
    - Sweden Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
      - Storage and Shipping
      - Order-to-cash
      - Title Model
      - DSCSA and Serialization Services
      - Pharmaceutical Sampling
      - Others
  - Norway
    - Norway Pharmaceutical Third-party Logistics (3PL) Market, By Product, 2018 - 2030 (USD Million)
      - Branded
      - Generic
      - Biosimilar
      - Vaccine
      - Cell Therapy
      - Gene Therapy
      - Others
    - Norway Pharmaceutical Third-party Logistics (3PL) Market, By Temperature, 2018 - 2030 (USD Million)
      - Ambient
      - Refrigerated
      - Frozen
      - Ultra-frozen/Deep-Frozen
      - Cryogenic
    - Norway Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
      - Oncology
      - Cardiovascular Diseases
      - Infectious Diseases
      - Neurology
      - Diabetes
      - Nephrology
      - Rheumatology
      - Allergy/Asthma
      - Gastroenterology
      - Ophthalmology
      - Others
    - Norway Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
      - Large
      - Medium
      - Small
    - Norway Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
      - Storage and Shipping
      - Order-to-cash
      - Title Model
      - DSCSA and Serialization Services
      - Pharmaceutical Sampling
      - Others
- Asia Pacific
  - Asia Pacific Pharmaceutical Third-party Logistics (3PL) Market, By Product, 2018 - 2030 (USD Million)
    - Branded
    - Generic
    - Biosimilar
    - Vaccine
    - Cell Therapy
    - Gene Therapy
    - Others
  - Asia Pacific Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
    - Ambient
    - Refrigerated
    - Frozen
    - Ultra-frozen/Deep-Frozen
    - Cryogenic
  - Asia Pacific Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
    - Oncology
    - Cardiovascular Diseases
    - Infectious Diseases
    - Neurology
    - Diabetes
    - Nephrology
    - Rheumatology
    - Allergy/Asthma
    - Gastroenterology
    - Ophthalmology
    - Others
  - Asia Pacific Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
    - Large
    - Medium
    - Small
  - Asia Pacific Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
    - Storage and Shipping
    - Order-to-cash
    - Title Model
    - DSCSA and Serialization Services
    - Pharmaceutical Sampling
    - Others
  - Japan
    - Japan Pharmaceutical Third-party Logistics (3PL) Market, By Product, 2018 - 2030 (USD Million)
      - Branded
      - Generic
      - Biosimilar
      - Vaccine
      - Cell Therapy
      - Gene Therapy
      - Others
    - Japan Pharmaceutical Third-party Logistics (3PL) Market, By Temperature, 2018 - 2030 (USD Million)
      - Ambient
      - Refrigerated
      - Frozen
      - Ultra-frozen/Deep-Frozen
      - Cryogenic
    - Japan Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
      - Oncology
      - Cardiovascular Diseases
      - Infectious Diseases
      - Neurology
      - Diabetes
      - Nephrology
      - Rheumatology
      - Allergy/Asthma
      - Gastroenterology
      - Ophthalmology
      - Others
    - Japan Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
      - Large
      - Medium
      - Small
    - Japan Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
      - Storage and Shipping
      - Order-to-cash
      - Title Model
      - DSCSA and Serialization Services
      - Pharmaceutical Sampling
      - Others
  - China
    - China Pharmaceutical Third-party Logistics (3PL) Market, By Product, 2018 - 2030 (USD Million)
      - Branded
      - Generic
      - Biosimilar
      - Vaccine
      - Cell Therapy
      - Gene Therapy
      - Others
    - China Pharmaceutical Third-party Logistics (3PL) Market, By Temperature, 2018 - 2030 (USD Million)
      - Ambient
      - Refrigerated
      - Frozen
      - Ultra-frozen/Deep-Frozen
      - Cryogenic
    - China Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
      - Oncology
      - Cardiovascular Diseases
      - Infectious Diseases
      - Neurology
      - Diabetes
      - Nephrology
      - Rheumatology
      - Allergy/Asthma
      - Gastroenterology
      - Ophthalmology
      - Others
    - China Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
      - Large
      - Medium
      - Small
    - China Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
      - Storage and Shipping
      - Order-to-cash
      - Title Model
      - DSCSA and Serialization Services
      - Pharmaceutical Sampling
      - Others
  - India
    - India Pharmaceutical Third-party Logistics (3PL) Market, By Product, 2018 - 2030 (USD Million)
      - Branded
      - Generic
      - Biosimilar
      - Vaccine
      - Cell Therapy
      - Gene Therapy
      - Others
    - India Pharmaceutical Third-party Logistics (3PL) Market, By Temperature, 2018 - 2030 (USD Million)
      - Ambient
      - Refrigerated
      - Frozen
      - Ultra-frozen/Deep-Frozen
      - Cryogenic
    - India Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
      - Oncology
      - Cardiovascular Diseases
      - Infectious Diseases
      - Neurology
      - Diabetes
      - Nephrology
      - Rheumatology
      - Allergy/Asthma
      - Gastroenterology
      - Ophthalmology
      - Others
    - India Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
      - Large
      - Medium
      - Small
    - India Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
      - Storage and Shipping
      - Order-to-cash
      - Title Model
      - DSCSA and Serialization Services
      - Pharmaceutical Sampling
      - Others
  - South Korea
    - South Korea Pharmaceutical Third-party Logistics (3PL) Market, By Product, 2018 - 2030 (USD Million)
      - Branded
      - Generic
      - Biosimilar
      - Vaccine
      - Cell Therapy
      - Gene Therapy
      - Others
    - South Korea Pharmaceutical Third-party Logistics (3PL) Market, By Temperature, 2018 - 2030 (USD Million)
      - Ambient
      - Refrigerated
      - Frozen
      - Ultra-frozen/Deep-Frozen
      - Cryogenic
    - South Korea Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
      - Oncology
      - Cardiovascular Diseases
      - Infectious Diseases
      - Neurology
      - Diabetes
      - Nephrology
      - Rheumatology
      - Allergy/Asthma
      - Gastroenterology
      - Ophthalmology
      - Others
    - South Korea Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
      - Large
      - Medium
      - Small
    - South Korea Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
      - Storage and Shipping
      - Order-to-cash
      - Title Model
      - DSCSA and Serialization Services
      - Pharmaceutical Sampling
      - Others
  - Australia
    - Australia Pharmaceutical Third-party Logistics (3PL) Market, By Product, 2018 - 2030 (USD Million)
      - Branded
      - Generic
      - Biosimilar
      - Vaccine
      - Cell Therapy
      - Gene Therapy
      - Others
    - Australia Pharmaceutical Third-party Logistics (3PL) Market, By Temperature, 2018 - 2030 (USD Million)
      - Ambient
      - Refrigerated
      - Frozen
      - Ultra-frozen/Deep-Frozen
      - Cryogenic
    - Australia Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
      - Oncology
      - Cardiovascular Diseases
      - Infectious Diseases
      - Neurology
      - Diabetes
      - Nephrology
      - Rheumatology
      - Allergy/Asthma
      - Gastroenterology
      - Ophthalmology
      - Others
    - Australia Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
      - Large
      - Medium
      - Small
    - Australia Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
      - Storage and Shipping
      - Order-to-cash
      - Title Model
      - DSCSA and Serialization Services
      - Pharmaceutical Sampling
      - Others
  - Thailand
    - Thailand Pharmaceutical Third-party Logistics (3PL) Market, By Product, 2018 - 2030 (USD Million)
      - Branded
      - Generic
      - Biosimilar
      - Vaccine
      - Cell Therapy
      - Gene Therapy
      - Others
    - Thailand Pharmaceutical Third-party Logistics (3PL) Market, By Temperature, 2018 - 2030 (USD Million)
      - Ambient
      - Refrigerated
      - Frozen
      - Ultra-frozen/Deep-Frozen
      - Cryogenic
    - Thailand Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
      - Oncology
      - Cardiovascular Diseases
      - Infectious Diseases
      - Neurology
      - Diabetes
      - Nephrology
      - Rheumatology
      - Allergy/Asthma
      - Gastroenterology
      - Ophthalmology
      - Others
    - Thailand Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
      - Large
      - Medium
      - Small
    - Thailand Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
      - Storage and Shipping
      - Order-to-cash
      - Title Model
      - DSCSA and Serialization Services
      - Pharmaceutical Sampling
      - Others
- Latin America
  - Latin America Pharmaceutical Third-party Logistics (3PL) Market, By Product, 2018 - 2030 (USD Million)
    - Branded
    - Generic
    - Biosimilar
    - Vaccine
    - Cell Therapy
    - Gene Therapy
    - Others
  - Latin America Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
    - Ambient
    - Refrigerated
    - Frozen
    - Ultra-frozen/Deep-Frozen
    - Cryogenic
  - Latin America Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
    - Oncology
    - Cardiovascular Diseases
    - Infectious Diseases
    - Neurology
    - Diabetes
    - Nephrology
    - Rheumatology
    - Allergy/Asthma
    - Gastroenterology
    - Ophthalmology
    - Others
  - Latin America Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
    - Large
    - Medium
    - Small
  - Latin America Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
    - Storage and Shipping
    - Order-to-cash
    - Title Model
    - DSCSA and Serialization Services
    - Pharmaceutical Sampling
    - Others
  - Brazil
    - Brazil Pharmaceutical Third-party Logistics (3PL) Market, By Product, 2018 - 2030 (USD Million)
      - Branded
      - Generic
      - Biosimilar
      - Vaccine
      - Cell Therapy
      - Gene Therapy
      - Others
    - Brazil Pharmaceutical Third-party Logistics (3PL) Market, By Temperature, 2018 - 2030 (USD Million)
      - Ambient
      - Refrigerated
      - Frozen
      - Ultra-frozen/Deep-Frozen
      - Cryogenic
    - Brazil Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
      - Oncology
      - Cardiovascular Diseases
      - Infectious Diseases
      - Neurology
      - Diabetes
      - Nephrology
      - Rheumatology
      - Allergy/Asthma
      - Gastroenterology
      - Ophthalmology
      - Others
    - Brazil Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
      - Large
      - Medium
      - Small
    - Brazil Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
      - Storage and Shipping
      - Order-to-cash
      - Title Model
      - DSCSA and Serialization Services
      - Pharmaceutical Sampling
      - Others
  - Argentina
    - Argentina Pharmaceutical Third-party Logistics (3PL) Market, By Product, 2018 - 2030 (USD Million)
      - Branded
      - Generic
      - Biosimilar
      - Vaccine
      - Cell Therapy
      - Gene Therapy
      - Others
    - Argentina Pharmaceutical Third-party Logistics (3PL) Market, By Temperature, 2018 - 2030 (USD Million)
      - Ambient
      - Refrigerated
      - Frozen
      - Ultra-frozen/Deep-Frozen
      - Cryogenic
    - Argentina Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
      - Oncology
      - Cardiovascular Diseases
      - Infectious Diseases
      - Neurology
      - Diabetes
      - Nephrology
      - Rheumatology
      - Allergy/Asthma
      - Gastroenterology
      - Ophthalmology
      - Others
    - Argentina Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
      - Large
      - Medium
      - Small
    - Argentina Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
      - Storage and Shipping
      - Order-to-cash
      - Title Model
      - DSCSA and Serialization Services
      - Pharmaceutical Sampling
      - Others
- MEA
  - MEA Pharmaceutical Third-party Logistics (3PL) Market, By Product, 2018 - 2030 (USD Million)
    - Branded
    - Generic
    - Biosimilar
    - Vaccine
    - Cell Therapy
    - Gene Therapy
    - Others
  - MEA Pharmaceutical Third-party Logistics (3PL) Market, by Temperature, 2018 - 2030 (USD Million)
    - Ambient
    - Refrigerated
    - Frozen
    - Ultra-frozen/Deep-Frozen
    - Cryogenic
  - MEA Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
    - Oncology
    - Cardiovascular Diseases
    - Infectious Diseases
    - Neurology
    - Diabetes
    - Nephrology
    - Rheumatology
    - Allergy/Asthma
    - Gastroenterology
    - Ophthalmology
    - Others
  - MEA Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
    - Large
    - Medium
    - Small
  - MEA Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
    - Storage and Shipping
    - Order-to-cash
    - Title Model
    - DSCSA and Serialization Services
    - Pharmaceutical Sampling
    - Others
  - South Africa
    - South Africa Pharmaceutical Third-party Logistics (3PL) Market, By Product, 2018 - 2030 (USD Million)
      - Branded
      - Generic
      - Biosimilar
      - Vaccine
      - Cell Therapy
      - Gene Therapy
      - Others
    - South Africa Pharmaceutical Third-party Logistics (3PL) Market, By Temperature, 2018 - 2030 (USD Million)
      - Ambient
      - Refrigerated
      - Frozen
      - Ultra-frozen/Deep-Frozen
      - Cryogenic
    - South Africa Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
      - Oncology
      - Cardiovascular Diseases
      - Infectious Diseases
      - Neurology
      - Diabetes
      - Nephrology
      - Rheumatology
      - Allergy/Asthma
      - Gastroenterology
      - Ophthalmology
      - Others
    - South Africa Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
      - Large
      - Medium
      - Small
    - South Africa Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
      - Storage and Shipping
      - Order-to-cash
      - Title Model
      - DSCSA and Serialization Services
      - Pharmaceutical Sampling
      - Others
  - Saudi Arabia
    - Saudi Arabia Pharmaceutical Third-party Logistics (3PL) Market, By Product, 2018 - 2030 (USD Million)
      - Branded
      - Generic
      - Biosimilar
      - Vaccine
      - Cell Therapy
      - Gene Therapy
      - Others
    - Saudi Arabia Pharmaceutical Third-party Logistics (3PL) Market, By Temperature, 2018 - 2030 (USD Million)
      - Ambient
      - Refrigerated
      - Frozen
      - Ultra-frozen/Deep-Frozen
      - Cryogenic
    - Saudi Arabia Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
      - Oncology
      - Cardiovascular Diseases
      - Infectious Diseases
      - Neurology
      - Diabetes
      - Nephrology
      - Rheumatology
      - Allergy/Asthma
      - Gastroenterology
      - Ophthalmology
      - Others
    - Saudi Arabia Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
      - Large
      - Medium
      - Small
    - Saudi Arabia Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
      - Storage and Shipping
      - Order-to-cash
      - Title Model
      - DSCSA and Serialization Services
      - Pharmaceutical Sampling
      - Others
  - UAE
    - UAE Pharmaceutical Third-party Logistics (3PL) Market, By Product, 2018 - 2030 (USD Million)
      - Branded
      - Generic
      - Biosimilar
      - Vaccine
      - Cell Therapy
      - Gene Therapy
      - Others
    - UAE Pharmaceutical Third-party Logistics (3PL) Market, By Temperature, 2018 - 2030 (USD Million)
      - Ambient
      - Refrigerated
      - Frozen
      - Ultra-frozen/Deep-Frozen
      - Cryogenic
    - UAE Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
      - Oncology
      - Cardiovascular Diseases
      - Infectious Diseases
      - Neurology
      - Diabetes
      - Nephrology
      - Rheumatology
      - Allergy/Asthma
      - Gastroenterology
      - Ophthalmology
      - Others
    - UAE Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
      - Large
      - Medium
      - Small
    - UAE Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
      - Storage and Shipping
      - Order-to-cash
      - Title Model
      - DSCSA and Serialization Services
      - Pharmaceutical Sampling
      - Others
  - Kuwait
    - Kuwait Pharmaceutical Third-party Logistics (3PL) Market, By Product, 2018 - 2030 (USD Million)
      - Branded
      - Generic
      - Biosimilar
      - Vaccine
      - Cell Therapy
      - Gene Therapy
      - Others
    - Kuwait Pharmaceutical Third-party Logistics (3PL) Market, By Temperature, 2018 - 2030 (USD Million)
      - Ambient
      - Refrigerated
      - Frozen
      - Ultra-frozen/Deep-Frozen
      - Cryogenic
    - Kuwait Pharmaceutical Third-party Logistics (3PL) Market, by Therapeutic Area, 2018 - 2030 (USD Million)
      - Oncology
      - Cardiovascular Diseases
      - Infectious Diseases
      - Neurology
      - Diabetes
      - Nephrology
      - Rheumatology
      - Allergy/Asthma
      - Gastroenterology
      - Ophthalmology
      - Others
    - Kuwait Pharmaceutical Third-party Logistics (3PL) Market, by Manufacturer Size, 2018 - 2030 (USD Million)
      - Large
      - Medium
      - Small
    - Kuwait Pharmaceutical Third-party Logistics (3PL) Market, by Service, 2018 - 2030 (USD Million)
      - Storage and Shipping
      - Order-to-cash
      - Title Model
      - DSCSA and Serialization Services
      - Pharmaceutical Sampling
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments